Literature DB >> 24326785

C1q nephropathy in children: clinical characteristics and outcome.

Vindya N Gunasekara1, Neil J Sebire, Kjell Tullus.   

Abstract

BACKGROUND: C1q nephropathy has been suggested as a separate disease entity. C1q positivity has also been described in association with nephrotic syndrome (NS) as a potential marker for worse outcome. The aims of this study were to describe the clinical characteristics, laboratory parameters and outcomes of 35 children whose renal histology revealed predominant mesangial C1q deposition and to investigate if the experience at our institution supports the above hypothesis.
METHOD: Clinical and pathological characteristics of all children whose kidney biopsies showed positive C1q staining were retrospectively recorded. The outcome of children with minimal change nephrotic syndrome (MCNS) and predominant mesangial C1q deposition based on C1q staining was compared with that of a concurrent group of children with MCNS with no such immune staining.
RESULTS: The median age of the patient cohort was 4.5 years (range 6 months to 16 years), 69 % were boys and 88 % presented with nephrotic syndrome (NS). Children with C1q staining and MCNS had more relapses (p = 0.001) and shorter relapse-free periods (p = 0.033) than those with negative immunostaining, but the long-term outcomes were similar in both groups.
CONCLUSION: Our data do not support C1q nephropathy as a separate diagnostic category. Children with MCNS and mesangial C1q deposition (staining) showed more relapses but no difference in long term renal outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24326785     DOI: 10.1007/s00467-013-2692-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  C1q nephropathy: a pediatric clinicopathologic study.

Authors:  S S Iskandar; M C Browning; W B Lorentz
Journal:  Am J Kidney Dis       Date:  1991-10       Impact factor: 8.860

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

4.  C1q nephropathy: a variant of focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Joshua A Schwimmer; M Barry Stokes; Samih Nasr; Robert L Seigle; Anthony M Valeri; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

5.  Clinicopathologic correlation of C1q nephropathy in children.

Authors:  Yuko Fukuma; Satoshi Hisano; Yoshie Segawa; Kazuhiko Niimi; Noboru Tsuru; Yoshitsugu Kaku; Ken Hatae; Yasuhiro Kiyoshi; Akihisa Mitsudome; Hiroshi Iwasaki
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860

Review 6.  Current status and issues of C1q nephropathy.

Authors:  Akiko Mii; Akira Shimizu; Yukinari Masuda; Emiko Fujita; Kaoru Aki; Masamichi Ishizaki; Shigeru Sato; Adam Griesemer; Yuh Fukuda
Journal:  Clin Exp Nephrol       Date:  2009-04-17       Impact factor: 2.801

7.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Kidney Dis       Date:  1985-08       Impact factor: 8.860

8.  Clinicopathologic correlation and outcome of C1q nephropathy.

Authors:  Satoshi Hisano; Yuko Fukuma; Yoshie Segawa; Kazuhiko Niimi; Yoshitsugu Kaku; Ken Hatae; Takao Saitoh; Morishige Takeshita; Hiroshi Iwasaki
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 8.237

9.  Pathology, clinical presentations, and outcomes of C1q nephropathy.

Authors:  Alenka Vizjak; Dusan Ferluga; Mojca Rozic; Anastazija Hvala; Jelka Lindic; Tanja Kersnik Levart; Vesna Jurcić; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

10.  Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Clin Pathol       Date:  1985-04       Impact factor: 2.493

View more
  7 in total

1.  C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.

Authors:  Kipyo Kim; Hyung-Eun Son; Ji-Young Ryu; Hajeong Lee; Seung Hyeok Han; Dong-Ryeol Ryu; Jin Ho Paik; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin; Se Won Oh
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

2.  Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?

Authors:  Rui Ma; Dengyan Wu; Zhiqin He; Qian Chang; Yonghong Yang
Journal:  Front Pediatr       Date:  2021-02-04       Impact factor: 3.418

3.  An Interesting Case of Nonlupus Full-House Nephropathy.

Authors:  Satyanand Sathi; Alok Sharma; Anil Kumar Garg; Virendra Singh Saini; Manoj Kumar Singh; Devinder Vohra; Arvind Trivedi
Journal:  Case Rep Nephrol       Date:  2021-12-28

Review 4.  Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.

Authors:  Sarangarajan Ranganathan
Journal:  Front Pediatr       Date:  2016-03-31       Impact factor: 3.418

5.  Glomerular Immune Deposits Are Predictive of Poor Long-Term Outcome in Patients with Adult Biopsy-Proven Minimal Change Disease: A Cohort Study in Korea.

Authors:  Sung Woo Lee; Mi-Yeon Yu; Seon Ha Baek; Shin-Young Ahn; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

Review 6.  C1q Nephropathy: The Unique Underrecognized Pathological Entity.

Authors:  Joe Devasahayam; Gowrishankar Erode-Singaravelu; Zeenat Bhat; Tony Oliver; Arul Chandran; Xu Zeng; Paramesh Dakshinesh; Unni Pillai
Journal:  Anal Cell Pathol (Amst)       Date:  2015-11-10       Impact factor: 2.916

7.  A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report.

Authors:  Sho Ishiwa; Koichi Kamei; Kanako Tanase-Nakao; Shinsuke Shibata; Kunihiro Matsunami; Ichiro Takeuchi; Mai Sato; Kenji Ishikura; Satoshi Narumi
Journal:  BMC Nephrol       Date:  2020-08-12       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.